OncoZenge AB(DE:8LY)
€0.28+0.01 (+23.48%)
DE:8LY
OncoZenge AB financials statements
€0.28
At close:+0.01 (+23.48%)
OncoZenge AB (8LY) Income Statement
0 Followers
OncoZenge AB Income Statement
Last quarter (Q2 2026), OncoZenge AB's total revenue was kr5.84M, an increase of 4891.45% from the same quarter last year. In Q2, OncoZenge AB's net income was kr-5.67M. See OncoZenge AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 2.66M | kr 1.00K | kr 3.00K | kr 0.00 | kr 0.00 | |
| kr -4.84M | kr 1.00K | kr 3.00K | kr 0.00 | kr 0.00 | |
| kr 11.03M | kr 8.69M | kr 15.90M | kr 43.57M | kr 4.89M | |
| Depreciation and Amortization | kr 0.00 | kr 0.00 | kr 23.17M | kr 23.17M | kr 0.00 |
| kr -15.87M | kr -8.69M | kr 7.27M | kr 2.77M | kr -4.89M | |
| kr -15.87M | kr -8.69M | kr -15.90M | kr -43.57M | kr -4.89M | |
| kr -70.00K | kr -3.00K | kr 0.00 | kr 0.00 | kr 0.00 | |
| kr -15.94M | kr -8.69M | kr -15.90M | kr -43.57M | kr -4.89M | |
| kr -15.94M | kr -8.69M | kr -15.90M | kr -46.65M | kr -3.89M | |
| Per Share Metrics | |||||
| Basic EPS | kr -1.31 | kr -0.74 | kr -1.36 | kr -3.98 | kr -0.33 |
| Diluted EPS | kr -1.31 | kr -0.74 | kr -1.36 | kr -3.98 | kr -0.33 |
| Weighted Average Shares Outstanding | 12.13M | 11.71M | 11.71M | 11.71M | 11.71M |
| Weighted Average Shares Outstanding (Diluted) | 12.13M | 11.71M | 11.71M | 11.71M | 11.71M |
Currency in SEK
